C12N 2795/14134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2795/14134 (Use of virus or viral component as vaccine) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 4
- Inventors
- 7
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Dendritic cell targeting filamentous phage-based cancer treatment vaccine10 Jul 2025US 2025/0222099 A1The University of Hong Kong
- Probiotic vaccines and related methods of use8 May 2025US 2025/0144193 A1Salvitus, Inc.
- Phagemid Vector24 Aug 2023US 2023/0265452 A1Imperial College Innovations Limited
- Phagemid Vector8 Nov 2018US 2018/0320200 A1Imperial Innovations Limited
Most cited
By later US patents